Welcome to Metaverse, Nebius (NASDAQ:…
…
TRENDING
0.0533 USD
217.71 USD
1.09 USD
0.0719 USD
0.0069 USD
0.08 USD
0.0493 USD
2.75 USD
0.0148 USD
0.0231 USD
6.32 USD
0.0312 USD
0.8997 USD
0.23 USD
0.032 USD
0.0705 USD
9.25 USD
0.018 USD
0.0223 USD
2.29 USD
Let’s make a deal, Merck (NYSE: MRK) to acquire Cidara for $9.2 billion Merck (NYSE: MRK) announced it will acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, valuing the transaction at approximately $9.2 billion. The acquisition centers on Cidara’s lead candidate CD388, an investigational antiviral agent currently in Phase 3 trials for influenza prevention. CD388 is designed to …